Icon PLC
(FRA:IJF)
€
293.4
0.6 (0.2%)
Market Cap: 24.15 Bil
Enterprise Value: 27.18 Bil
PE Ratio: 38.12
PB Ratio: 2.75
GF Score: 96/100 - Q1 2024 ICON PLC Earnings Call TranscriptApr 25, 2024€286 (-2.09%)Earnings
- Q4 2023 ICON PLC Earnings Call TranscriptFeb 22, 2024€260.6 (+0.42%)Earnings
- ICON PLC at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- ICON PLC at Evercore ISI HealthCONx Conference TranscriptNov 29, 2023
- ICON PLC at Jefferies London Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 ICON PLC Earnings Call TranscriptOct 26, 2023€222 (+3.79%)Earnings
- Q2 2023 ICON PLC Earnings Call TranscriptJul 27, 2023€227.1 (+1.11%)Earnings
- ICON PLC at William Blair Growth Stock Conference TranscriptJun 06, 2023
- Q1 2023 ICON PLC Earnings Call TranscriptApr 27, 2023€180.75 (-1.26%)Earnings
- ICON PLC at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- ICON PLC at Citi Healthcare & Medtech Conference TranscriptMar 02, 2023
- Q4 2022 ICON PLC Earnings Call TranscriptFeb 23, 2023€206Earnings
- ICON PLC at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 ICON PLC Earnings Call TranscriptNov 03, 2022€212 (+6.00%)Earnings
- Q2 2022 ICON PLC Earnings Call TranscriptJul 28, 2022€224 (+2.75%)Earnings
- Q1 2022 ICON PLC Earnings Call TranscriptApr 28, 2022€216 (+9.64%)Earnings
- ICON PLC Analyst Day TranscriptMar 17, 2022
- ICON PLC at Citi Healthcare Conference (Virtual) TranscriptFeb 24, 2022
- Full Year 2021 ICON PLC Earnings Call TranscriptFeb 22, 2022€195 (-2.01%)Earnings
- ICON PLC at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- ICON PLC at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2021
- Q3 2021 ICON PLC Earnings Call TranscriptNov 04, 2021€236 (+0.85%)Earnings
- Q2 2021 ICON PLC Earnings Call TranscriptJul 22, 2021€183 (+2.81%)Earnings
- ICON PLC at UBS Global Healthcare Virtual Conference TranscriptMay 24, 2021
- ICON PLC at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q1 2021 ICON PLC Earnings Call TranscriptApr 29, 2021€177Earnings
- ICON PLC at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Full Year 2020 ICON PLC Earnings and to Discuss Acquisition of PRA Health Sciences Inc Call TranscriptFeb 24, 2021
- ICON PLC at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- ICON PLC at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 ICON PLC Earnings Call TranscriptOct 22, 2020€168 (-4.00%)Earnings
- Q2 2020 ICON PLC Earnings Call TranscriptJul 23, 2020€168 (+3.07%)Earnings
- ICON PLC at UBS Global Healthcare Conference (Virtual) TranscriptMay 20, 2020
- Q1 2020 ICON PLC Earnings Call TranscriptApr 23, 2020Earnings
- ICON PLC at Barclays Global Healthcare Conference TranscriptMar 10, 2020
- Full Year 2019 ICON PLC Earnings Call TranscriptFeb 20, 2020Earnings
- ICON PLC at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Q3 2019 ICON PLC Earnings Call TranscriptOct 24, 2019Earnings
- Q2 2019 ICON PLC Earnings Call TranscriptJul 25, 2019Earnings
- ICON PLC at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Q1 2019 ICON PLC Earnings Call TranscriptMay 02, 2019Earnings
- ICON PLC at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Full Year 2018 ICON PLC Earnings Call TranscriptFeb 21, 2019Earnings
ICON PLC at Evercore ISI HealthCONx Conference Transcript
Nov 29, 2023 / 05:30PM GMT
Release Date Price:
€243
(-0.90%)
Elizabeth Hammell Anderson
Evercore ISI Institutional Equities, Research Division - MD & Fundamental Research Analyst
All right. Hi, everybody. Thanks so much for joining us this afternoon. I'm Elizabeth Anderson. I'm the healthcare technology and distribution analyst here at Evercore. Very pleased to be joined by ICON, Brendan Brennan, CFO as many of you know. Kate Haven, IR, as many of you probably also know as well.
Questions & Answers
Elizabeth Hammell Anderson
Evercore ISI Institutional Equities, Research Division - MD & Fundamental Research Analyst
Okay. So maybe just to kick it off with sort of the question of the hour for the last many hours. Investors continue to be worried about a slowdown in pharma R&D spend. So how -- can you kind of give us a lay of the landscape right now? And how do you think about tracking it as we've gone through the last couple of months?
Brendan Brennan
ICON Public Limited Company - CFO
Yes, it's been an interesting period. We've obviously seen probably 2
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)